Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
CNS Pharmaceuticals, Inc. (CNSP) had Debt to Equity Ratio of 3.29 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.94M |
|
-- |
|
-- |
|
$4.98M |
|
$-4.98M |
|
$0.04M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.94M |
|
$-4.98M |
|
$-4.97M |
|
0.68M |
|
0.68M |
|
$-7.30 |
|
$-7.30 |
|
| Balance Sheet Financials | |
$4.08M |
|
$0.02M |
|
$0.57M |
|
$4.65M |
|
$4.58M |
|
-- |
|
-- |
|
$4.58M |
|
$0.07M |
|
$0.07M |
|
$0.07M |
|
0.81M |
|
| Cash Flow Statement Financials | |
$-4.65M |
|
$-0.01M |
|
$0.40M |
|
$7.20M |
|
$2.95M |
|
$-4.25M |
|
$0.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.89 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
3.29 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6982.18% |
|
-6982.60% |
|
-106.10% |
|
-6982.60% |
|
$0.09 |
|
$-6.89 |
|
$-6.88 |
|